Case Report: A delicate equilibrium of exocrine pancreatic recovery and hepatotoxicity with elexacaftor/tezacaftor/ivacaftor therapy in a pediatric patient with cystic fibrosis

• Päätekijät: Michael P. Coughlin (Tekijä), Senthilkumar Sankararaman (Tekijä), Erica A. Roesch (Tekijä), Emily D. Certo (Tekijä), Benjamin L. Brej (Tekijä), Michael W. Konstan (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

This case report presents a comprehensive evaluation of the complex balance of therapeutic benefits and potential risks associated with the cystic fibrosis transmembrane conductance regulator (CFTR) modulator elexacaftor/tezacaftor/ivacaftor (ETI) therapy in managing an eight-year-old male with cyst...